Cavicchi M, Gibbs L, Whittle B J
William Harvey Research Institute, St Bartholomew's and the Royal London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK.
Gut. 2000 Dec;47(6):771-8. doi: 10.1136/gut.47.6.771.
The inducible isoform of nitric oxide synthase (iNOS) may be involved in the mucosal injury associated with inflammatory bowel disease (IBD). In contrast with iNOS, the inducible heme oxygenase 1 (HO-1) is considered to act as a protective antioxidant system.
To evaluate the effects of the known HO-1 inducers, cadmium and bismuth salts, heme, and nitric oxide (NO) donors, on iNOS activity, and expression in the human intestinal epithelial cell line DLD-1.
iNOS activity was assessed by the Griess reaction and the radiochemical L-arginine conversion assay. iNOS mRNA and iNOS protein expression were determined by northern and western blotting, respectively.
Cytokine exposure led to induction of iNOS activity, iNOS mRNA, and iNOS protein expression. Preincubation of DLD-1 cells with heme (1-50 microM) inhibited cytokine induced iNOS activity in a concentration dependent manner. This inhibitory effect was abolished by the HO-1 specific inhibitor tin protoporphyrin. Preincubation with NO donors sodium nitroprusside (SNP 1-1000 microM) or S-nitroso-acetyl-penicillamine (SNAP 1-1000 microM), or with the heavy metals cadmium chloride (10-40 microM), bismuth citrate, or ranitidine bismuth citrate (10-3000 microM) inhibited iNOS activity in a concentration dependent manner. Moreover, SNP and heme abolished cytokine induced iNOS protein as well as iNOS mRNA expression, whereas cadmium chloride did not modify iNOS protein expression.
Heme, the heavy metals cadmium and bismuth, as well as NO donors, are potent inhibitors of cytokine induced iNOS activity. Heme and NO donors act at the transcriptional level inhibiting iNOS mRNA expression. Such findings suggest the potential for interplay between the iNOS and HO-1 systems, which may modulate the progress of IBD.
一氧化氮合酶(iNOS)的诱导型同工型可能参与了与炎症性肠病(IBD)相关的黏膜损伤。与iNOS相反,诱导型血红素加氧酶1(HO-1)被认为起着保护性抗氧化系统的作用。
评估已知的HO-1诱导剂镉盐、铋盐、血红素和一氧化氮(NO)供体对人肠上皮细胞系DLD-1中iNOS活性及表达的影响。
通过格里斯反应和放射化学L-精氨酸转化试验评估iNOS活性。分别通过Northern印迹法和Western印迹法测定iNOS mRNA和iNOS蛋白表达。
细胞因子暴露导致iNOS活性、iNOS mRNA和iNOS蛋白表达的诱导。用血红素(1 - 50 μM)预孵育DLD-1细胞以浓度依赖性方式抑制细胞因子诱导的iNOS活性。HO-1特异性抑制剂锡原卟啉消除了这种抑制作用。用NO供体硝普钠(SNP 1 - 1000 μM)或S-亚硝基乙酰青霉胺(SNAP 1 - 1000 μM),或与重金属氯化镉(10 - 40 μM)、柠檬酸铋或雷尼替丁枸橼酸铋(10 - 3000 μM)预孵育以浓度依赖性方式抑制iNOS活性。此外,SNP和血红素消除了细胞因子诱导的iNOS蛋白以及iNOS mRNA表达,而氯化镉未改变iNOS蛋白表达。
血红素、重金属镉和铋以及NO供体是细胞因子诱导的iNOS活性的有效抑制剂。血红素和NO供体在转录水平起作用,抑制iNOS mRNA表达。这些发现提示iNOS和HO-1系统之间可能存在相互作用,这可能调节IBD的进展。